161 related articles for article (PubMed ID: 20418939)
1. Development of a Bayesian classifier for breast cancer risk stratification: a feasibility study.
Stojadinovic A; Eberhardt C; Henry L; Eberhardt J; Elster EA; Peoples GE; Nissan A; Shriver CD
Eplasty; 2010 Mar; 10():e25. PubMed ID: 20418939
[TBL] [Abstract][Full Text] [Related]
2. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
3. A GMM-based breast cancer risk stratification using a resonance-frequency electrical impedance spectroscopy.
Lederman D; Zheng B; Wang X; Sumkin JH; Gur D
Med Phys; 2011 Mar; 38(3):1649-59. PubMed ID: 21520878
[TBL] [Abstract][Full Text] [Related]
4. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
[TBL] [Abstract][Full Text] [Related]
5. Electrical impedance scanning for the early detection of breast cancer in young women: preliminary results of a multicenter prospective clinical trial.
Stojadinovic A; Nissan A; Gallimidi Z; Lenington S; Logan W; Zuley M; Yeshaya A; Shimonov M; Melloul M; Fields S; Allweis T; Ginor R; Gur D; Shriver CD
J Clin Oncol; 2005 Apr; 23(12):2703-15. PubMed ID: 15837985
[TBL] [Abstract][Full Text] [Related]
6. The Value of Tyrer-Cuzick Versus Gail Risk Modeling in Predicting Benefit from Screening MRI in Breast Cancer.
Sevdalis A; Deng X; Bandyopadhyay D; McGuire KP
Eur J Breast Health; 2022 Jan; 18(1):79-84. PubMed ID: 35059595
[TBL] [Abstract][Full Text] [Related]
7. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
Zhang L; Jie Z; Xu S; Zhang L; Guo X
Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age.
MacKarem G; Roche CA; Hughes KS
Breast J; 2001; 7(1):34-9. PubMed ID: 11348413
[TBL] [Abstract][Full Text] [Related]
10. Lifetime and 5 years risk of breast cancer and attributable risk factor according to Gail model in Iranian women.
Mohammadbeigi A; Mohammadsalehi N; Valizadeh R; Momtaheni Z; Mokhtari M; Ansari H
J Pharm Bioallied Sci; 2015; 7(3):207-11. PubMed ID: 26229355
[TBL] [Abstract][Full Text] [Related]
11. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
[TBL] [Abstract][Full Text] [Related]
12. Assessing Breast Cancer Risk Estimates Based on the Gail Model and Its Predictors in Qatari Women.
Bener A; Çatan F; El Ayoubi HR; Acar A; Ibrahim WH
J Prim Care Community Health; 2017 Jul; 8(3):180-187. PubMed ID: 28606030
[TBL] [Abstract][Full Text] [Related]
13. Development of a clinical decision model for thyroid nodules.
Stojadinovic A; Peoples GE; Libutti SK; Henry LR; Eberhardt J; Howard RS; Gur D; Elster EA; Nissan A
BMC Surg; 2009 Aug; 9():12. PubMed ID: 19664278
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of electrical impedance scanning for identifying young women at risk for breast cancer.
Stojadinovic A; Moskovitz O; Gallimidi Z; Fields S; Brooks AD; Brem R; Mucciola RN; Singh M; Maniscalco-Theberge M; Rockette HE; Gur D; Shriver CD
Breast Cancer Res Treat; 2006 May; 97(2):179-89. PubMed ID: 16491309
[TBL] [Abstract][Full Text] [Related]
15. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
[TBL] [Abstract][Full Text] [Related]
16. Validation of risk assessment models for predicting the incidence of breast cancer in korean women.
Min JW; Chang MC; Lee HK; Hur MH; Noh DY; Yoon JH; Jung Y; Yang JH;
J Breast Cancer; 2014 Sep; 17(3):226-35. PubMed ID: 25320620
[TBL] [Abstract][Full Text] [Related]
17. Electrical impedance scanning as a new breast cancer risk stratification tool for young women.
Stojadinovic A; Nissan A; Shriver CD; Mittendorf EA; Akin MD; Dickerson V; Lenington S; Platt LD; Stavros T; Goldstein SR; Moskovitz O; Gallimidi Z; Fields SI; Yeshaya A; Allweis TM; Manassa R; Pappo I; Ginor RX; D'Agostino RB; Gur D
J Surg Oncol; 2008 Feb; 97(2):112-20. PubMed ID: 18050282
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Gail Model in Estimating the Risk of Breast Cancer: Effect of Cancer Worry and Risk in Healthy Women.
Bener A; Barışık CC; Acar A; Özdenkaya Y
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1765-1771. PubMed ID: 31244298
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
